APA (7e ed.) Bronvermelding

Verhelst, J., Froud, A., Touzel, R., Wass, J., Besser, G., & Grossman, A. (1991). Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: A double-blind study.

Chicago (17e ed.) Bronvermelding

Verhelst, J., A. Froud, R. Touzel, J. Wass, G. Besser, en AB Grossman. Acute and Long-term Effects of Once-daily Oral Bromocriptine and a New Long-acting Non-ergot Dopamine Agonist, Quinagolide, in the Treatment of Hyperprolactinemia: A Double-blind Study. 1991.

MLA (9e ed.) Bronvermelding

Verhelst, J., et al. Acute and Long-term Effects of Once-daily Oral Bromocriptine and a New Long-acting Non-ergot Dopamine Agonist, Quinagolide, in the Treatment of Hyperprolactinemia: A Double-blind Study. 1991.